DZ Bank
TBPH icon

DZ Bank’s Theravance Biopharma TBPH Stock Holding History

DZ Bank’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.1M Hold
64,533
– – ﹤0.01% 735
2026
Q1 		$1.05M Buy
64,533
+38,998
+153% +$690K ﹤0.01% 714
2025
Q4 		$478K Hold
25,535
– – ﹤0.01% 796
2025
Q3 		$373K Buy
+25,535
New +$323K ﹤0.01% 800
2018
Q2 		– Sell
-51,134
Closed -$1.24M – 1075
2018
Q1 		$1.24M Buy
+51,134
New +$1.4M ﹤0.01% 616

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
ICM
Irenic Capital Management New York $2.08B AUM 19.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

DZ Bank's TBPH Position: Q2 2026 in Review

DZ Bank held its Theravance Biopharma (TBPH) position steady in Q2 2026 at 64,533 shares worth $1.1M. The position accounts for ﹤0.01% of the portfolio, ranked #735.

DZ Bank first reported a position in TBPH in Q1 2018 and has held it in 5 quarters since. The position peaked at $1.24M in Q1 2018. 179 funds tracked by Wall St. Rank hold TBPH as of Q2 2026.

  • DZ Bank held 64,533 shares of Theravance Biopharma worth $1.1M as of Q2 2026.
  • DZ Bank left its Theravance Biopharma share count unchanged in Q2 2026.
  • Theravance Biopharma made up ﹤0.01% of DZ Bank's portfolio in Q2 2026, its #735 holding.
  • DZ Bank first reported a position in Theravance Biopharma in Q1 2018 and has held it in 5 quarters since.
  • DZ Bank's Theravance Biopharma position peaked at $1.24M in Q1 2018.
  • 179 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2026.

Based on DZ Bank's 13F filing for Q2 2026, filed 14 Aug 2026.